Literature DB >> 32078445

Intestinal Flora Modulates Blood Pressure by Regulating the Synthesis of Intestinal-Derived Corticosterone in High Salt-Induced Hypertension.

Xuefang Yan1, Jiajia Jin1, Xinhuan Su2,3, Xianlun Yin1, Jing Gao1, Xiaowei Wang1, Shucui Zhang1, Peili Bu1, Mansen Wang4, Yun Zhang1, Zhe Wang2,3, Qunye Zhang1.   

Abstract

RATIONALE: High-salt diet is one of the most important risk factors for hypertension. Intestinal flora has been reported to be associated with high salt-induced hypertension (hSIH). However, the detailed roles of intestinal flora in hSIH pathogenesis have not yet been fully elucidated.
OBJECTIVE: To reveal the roles and mechanisms of intestinal flora in hSIH development. METHODS AND
RESULTS: The abovementioned issues were investigated using various techniques including 16S rRNA gene sequencing, untargeted metabolomics, selective bacterial culture, and fecal microbiota transplantation. We found that high-salt diet induced hypertension in Wistar rats. The fecal microbiota of healthy rats could dramatically lower blood pressure (BP) of hypertensive rats, whereas the fecal microbiota of hSIH rats had opposite effects. The composition, metabolism, and interrelationship of intestinal flora in hSIH rats were considerably reshaped, including the increased corticosterone level and reduced Bacteroides and arachidonic acid levels, which tightly correlated with BP. The serum corticosterone level was also significantly increased in rats with hSIH. Furthermore, the above abnormalities were confirmed in patients with hypertension. The intestinal Bacteroides fragilis could inhibit the production of intestinal-derived corticosterone induced by high-salt diet through its metabolite arachidonic acid.
CONCLUSIONS: hSIH could be transferred by fecal microbiota transplantation, indicating the pivotal roles of intestinal flora in hSIH development. High-salt diet reduced the levels of B fragilis and arachidonic acid in the intestine, which increased intestinal-derived corticosterone production and corticosterone levels in serum and intestine, thereby promoting BP elevation. This study revealed a novel mechanism different from inflammation/immunity by which intestinal flora regulated BP, namely intestinal flora could modulate BP by affecting steroid hormone levels. These findings enriched the understanding of the function of intestinal flora and its effects on hypertension.

Entities:  

Keywords:  arachidonic acid; bacteroides; corticosterone; hypertension; microbiota

Year:  2020        PMID: 32078445     DOI: 10.1161/CIRCRESAHA.119.316394

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  36 in total

Review 1.  Gut microbiota as a transducer of dietary cues to regulate host circadian rhythms and metabolism.

Authors:  Hyoann Choi; Mrinalini C Rao; Eugene B Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-17       Impact factor: 46.802

Review 2.  Recent advances in modulation of cardiovascular diseases by the gut microbiota.

Authors:  Sepiso K Masenga; Benson Hamooya; Joy Hangoma; Valerie Hayumbu; Lale A Ertuglu; Jeanne Ishimwe; Sharla Rahman; Mohammad Saleem; Cheryl L Laffer; Fernando Elijovich; Annet Kirabo
Journal:  J Hum Hypertens       Date:  2022-04-25       Impact factor: 3.012

3.  Detection of low-mineral- and high-salt responsible caecal indigenous bacteria in ICR mice.

Authors:  Yumeng Xia; Takashi Kuda; Saori Nakamura; Hajime Takahashi; Bon Kimura
Journal:  3 Biotech       Date:  2022-02-05       Impact factor: 2.406

Review 4.  Role of the microbiota in hypertension and antihypertensive drug metabolism.

Authors:  Eikan Mishima; Takaaki Abe
Journal:  Hypertens Res       Date:  2021-12-09       Impact factor: 3.872

Review 5.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

Review 6.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

Review 7.  Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.

Authors:  Haley B Overby; Jane F Ferguson
Journal:  Curr Hypertens Rep       Date:  2021-02-03       Impact factor: 5.369

Review 8.  Sequence meets function-microbiota and cardiovascular disease.

Authors:  Myungsuk Kim; Md Nazmul Huda; Brian J Bennett
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

Review 9.  Gut-brain-bone marrow axis in hypertension.

Authors:  Jing Li; Mohan K Raizada; Elaine M Richards
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-03-01       Impact factor: 2.894

Review 10.  Diet-related gut microbial metabolites and sensing in hypertension.

Authors:  Rikeish R Muralitharan; Francine Z Marques
Journal:  J Hum Hypertens       Date:  2020-07-30       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.